James Basta, EVP, General Counsel at Intellia Therapeutics, Inc. (NTLA), sold 7,610 shares at $29.46 ($224K) on 2024-01-03, disclosed to the SEC on 2024-01-05.
Open-market sale of $224k NTLA by EVP, General Counsel. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.46 | 3,805 | $112K | 50.0% |
| 2 | $29.46 | 3,805 | $112K | 50.0% |
| Total | $29.46 avg | 7,610 | $224K | 100% |
| Filing → |
| NTLA | SELL | 2025-03-04 | $23K | — | Filing → |
| NTLA | SELL | 2025-01-07 | $172K | — | Filing → |
| NTLA | SELL | 2024-03-05 | $152K | — | Filing → |